Background: Indirect calorimetry (IC) with metabolic monitors is widely used for noninvasive assessment of energy expenditure and macronutrient oxidation in health and disease. Objective: To overcome deficiencies in validity and reliability of metabolic monitors, we established a procedure that allowed correction for monitor-specific deviations. Design: Randomized comparative IC (canopy mode) with the Deltatrac MBM-100 (Datex) and Vmax Encore 29n (SensorMedix) was performed in postabsorptive (overnight fast .8 h) healthy subjects (n = 40). In vitro validation was performed by simulation of oxygen consumption (VO 2 ) and carbon dioxide output (VCO 2 ) rates by using mass-flow regulators and pure gases. A simulation-based postcalorimetric calibration of cart readouts [individual calibration control evaluation (ICcE)] was established in adults (n = 24). Results: The comparison of carefully calibrated monitors showed marked differences in VCO 2 and VO 2 (P , 0.01) and derived metabolic variables [resting energy expenditure (REE), respiratory quotient (RQ), glucose/carbohydrate oxidation (Gox), and fat oxidation (Fox); P , 0.001]. Correlations appeared to be acceptable for breath gas rates and REE (R 2 w 0.9) but were unacceptable for RQ (R 2 = 0.3), Gox, and Fox (R 2 = 0.2). In vitro simulation experiments showed monitor-dependent interferences for VCO 2 and VO 2 as follows: 1) within series, nonlinear and variable deviations of monitor readouts at different exchange rates; 2) between series, differences and unsteady variability; and 3) differences in individual monitor characteristics (eg, rate dependence, stability, imprecision). The introduction of the postcalorimetric recalibration by ICcE resulted in an adjustment of gas exchange rates and the derived metabolic variables with reasonable correlations (R 2 . 0.9). Conclusions: Differential, metabolic, monitor-specific deviations are the primary determinants for lack of accuracy, comparability, and transferability of results. This problem can be overcome by the present postcalorimetric ICcE procedure.
INTRODUCTION
Indirect calorimetry (IC) 4 is a noninvasive method for the determination of energy expenditure by respiratory gas exchange analysis. The principles of IC were established in the 19th century (1) (2) (3) . With the use of appropriate devices (metabolic monitor or cart), the rates of carbon dioxide output (VCO 2 ) and oxygen consumption (VO 2 ) are typically assessed under resting conditions. The data are used for calculation of resting energy expenditure (REE) and the respiratory quotient (RQ). The method also allows estimation of the differential contribution of macronutrient oxidation (ie, carbohydrate, fat, protein) to REE in vivo when protein oxidation is additionally evaluated. The procedure is well established and allows far more accurate estimates of REE than all of the available formula-based approaches (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) .
An early clinical application was for diagnosis of thyroid dysfunction. Today, IC is of interest for evaluation of REE, eg, in intensive care units for assessment of caloric needs in severely ill patients (14, 16, 17) . Experimental applications of IC in humans are widespread, eg, for studies on macronutrient oxidation, assessment of thermogenesis, measurement of energy expenditure during rest and muscular exercise, and exploration of pathogenesis of obesity and diabetes mellitus (5, 7, 18, 19) .
Despite its broad use, IC has some limitations. In particular, commercially manufactured devices may differ in technical construction and analytic performance. For assessment of REE and RQ in humans, flow-through respirometry (ventilated hood/ canopy mode) is the method of choice in the clinical and the experimental setting. Among canopy-based metabolic carts, the Deltatrac MBM-100 (Datex) is one of the most widespread used devices. The Deltatrac was supposed to exhibit the greatest accuracy and the least intercart variability of all such devices worldwide. Because this cart is no longer produced, there is a need for replacement by contemporary metabolic monitors (14, (20) (21) (22) (23) (24) (25) .
We here report on a comparative evaluation of the validity and reliability of 2 metabolic carts by applying simulation experiments in vitro. The results showed relevant deficiencies in cart performances, which led us to develop a specific postcalorimetric calibration procedure allowing us to control for cart-dependent inaccuracy and variability in measurements with any canopybased metabolic monitor.
SUBJECTS AND METHODS

Subjects
Inclusion criteria for participation in the IC studies were age .18 y and written informed consent. Exclusion criteria were the presence of an acute or chronic illness, pregnancy or breastfeeding in women, and contravention of the requirements of the study. Initial recruitment started in March 2008.
All subjects received detailed preparatory oral and printed information on the aims and prerequisites of the study. The following requirements for REE measurements were specifically stressed: 1) absence of vigorous physical activity or alcohol abuse for 20 h, 2) no intake of food or drinks other than water for at least 8 h, 3) abstention from nicotine for 3 h, 4) restriction of any physical activity in the morning of the study day to the absolute necessary minimum, and 5) arrival in the metabolic unit at 0800 (60.5 h). Adherence to these guidelines was inquired for just before the measurements. Subsequent to the REE measurements, the participants underwent bioimpedance analysis (Body Impedance Analyzer Nutrigard-S; Data Inputy) for assessment of fat mass and lean body mass, and a generous breakfast was served after the tests.
The study protocol was examined and approved by the ethics committee of the University of Düsseldorf.
The following 3 cohorts participated in this study. The anthropometric data are summarized in Table 1 .
Cohort 1 (cart comparison cohort):
A total of 40 healthy adults participated in the metabolic monitor comparison study. Cohort 2 (cart evaluation cohort): This group comprised 22 healthy adults. In this series, the mean rates of CO 2 production and O 2 consumption in vivo as read out by the metabolic carts were calibrated for each individual in a direct subsequent in vitro simulation experiment (massflow meter regulated infusion of pure gaseous CO 2 and N 2 ). Cohort 3 (intraindividual variability cohort): Each of 6 healthy adult subjects underwent multiple REE measurements on 4 different study days. The mean (6SD) total observation period was 21 6 5 wk (median: 21 wk; range: 14-16 wk), and the mean (6SD) interval between measurements was 7 6 5 wk (median: 6 wk; range: 4-16 wk).
Metabolic monitors and measurements
Carts
Two flow-through system metabolic carts allowing gas dilutionbased canopy-mode measurements were comparatively evaluated: 1) the Deltatrac MBM-100 (Datex), equipped with an infrared CO 2 sensor and a differential paramagnetic O 2 sensor and fixed mass flow (40 L/min), and 2) the Vmax Encore 29n (SensorMedix; delivered by Cardinal Health Germany) with an infrared CO 2 sensor and an electrochemical O 2 sensor and equipped with a variable mass flow.
Maintenance was performed on the Deltatrac and the Vmax Encore before the study and the devices were checked extensively for adequate performance by the authorized technical service units at GE Health Care and Cardinal Health Germany, respectively. Before each use in the metabolic unit, the carts were prepared and calibrated according to the manufacturers' instructions.
The Deltatrac and Vmax Encore provide VCO 2 and VO 2 in milliliters per minute and liters per minute, respectively, with the readout adjusted to standard temperature pressure dry conditions at temperature = 273 K and pressure = 1013 hPa.
Energy expenditure measurements
The subjects arrived at w0800; they were allowed to void and were then asked to lie down in comfortable beds in a quiet special study room. Overall, study conditions were in accordance with recommended best practice guidelines (16, 17) . The room temperature was 20-228C, and blankets were available when requested. After a resting period (10 min), the canopy of one of the metabolic carts was positioned over the participant's head and IC measurement was started with an initial 10-min period to accustom the participant to the device and for equilibration. Subsequently, a 20-min recording period followed while the subject remained under strict resting conditions. Data readout (ie, VCO 2 and VO 2 ) was set at the highest available frequency (ie, Deltatrac: 1 readout/min; Vmax Encore, 3 readouts/min). After a second resting period (10 min), the subject received a second canopy measurement with the other metabolic cart with the use of the same time protocol as in the first measurement. In general, 2 subjects were investigated in parallel with both carts, and the sequence of cart use was randomly assigned throughout the trials. Preparatory measures, calibration procedures, and IC measurements were performed or supervised by one researcher with special experience and expertise.
Gas-exchange simulation studies
In vitro, CO 2 production and O 2 consumption were simulated by infusion of gaseous CO 2 (purity: 4.5) and N 2 (purity: 5.0), respectively, by using a high-precision mass-flow regulator (series 358; range: 0-2 L/min; Analyt-MTC) calibrated to standard conditions (temperature = 273 K, pressure = 1013 hPa). On the basis of the known infused mass flow V infusedCO 2 and V infusedN 2 , the expected readouts of the metabolic carts were then calculated as V calcCO 2 and as V calcO 2 , respectively, as given below.
Initial experiments conducted in canopy mode with an artificial head model showed that steady state conditions were established within a time period comparable to the in vivo measurements. We then examined a direct mode. Artificial head and canopy were omitted and gaseous CO 2 and N 2 were directly introduced via the mass-flow regulator into the canopy hose of the metabolic cart (canopy removed; see Supplemental Scheme 1 under "Supplemental data" in the online issue). In the direct mode, steady state conditions were reached within a few minutes and the cart readouts were identical in both modes with either cart. The more rapid direct mode was therefore applied in the subsequent in vitro experiments.
In vitro, the experimental conditions required throughout were as follows: VCO 2 and VO 2 between 0.1 and 0.5 L/min, with VCO 2 :VO 2 ratios in the range of 0.6-1.1 and, with the Vmax Encore, an additional expiratory CO 2 (FeCO 2 ) in the range of 0.6-0.9%. After a 5-min equilibration period, 10-min data recordings were performed under steady state conditions with maximal rates of data readout (see above). In these experiments, the mean within-series CVs of the Deltatrac readouts were 0.33 6 0.25% (median: 0.28%; range: 0.00-1.82%) for VCO 2 and 0.56 6 0.36% (0.46%; 0.00-1.82%) for VO 2 . The respective mean CVs of the Vmax Encore were 0.56 6 0.17% (0.53%; 0.26-0.17%) for VCO 2 and 0.88 6 0.31% (0.82%; 0.27-1.89%) for VO 2 . Of note, the CVs tended to be higher at lower gas-flow rates.
Case-related in vitro validation by individual calibration control evaluation
In a set of IC measurements in vivo, the metabolic cart readouts of VCO 2 and VO 2 were obtained as described above and then specifically validated by a subsequent in vitro simulation as follows. The means of the in vivo rates were calculated. Thereafter, gaseous CO 2 and N 2 were infused into the hose of the metabolic cart and the mass-flow meters adjusted until the mean rates as observed in an individual subject were exactly met. The resulting adjustment of the mass-flow regulator (in L/min, standard conditions; temperature = 273 K, pressure = 1013 hPa) was then taken to calculate the estimate for the true breath gas exchange rate for the subject (see below).
Data analysis and statistics
In vivo studies
The serial readouts of VCO 2 and VO 2 (in mL/min) were used to calculate the RQ
and the REE according to the abbreviated Weir equation (4)
which is equivalent to
The data presented are the within-series means of the 20 and 60 data points as obtained by the 20-min recordings with the Deltatrac and the Vmax Encore, respectively.
The proportional energy contribution of macronutrient oxidation [glucose/carbohydrate oxidation (Gox; %); fat oxidation (Fox; %); protein oxidation (Pox; %)] to REE was estimated on the basis of the assumption that Pox provided 15% of total REE (ie, Pox% = 15) in healthy subjects under postabsorptive conditions (overnight fast .8 h) (26) because urinary nitrogen excretion was not measured in these short-term experiments.
By using Atwater units of 16.74, 37.24, and 16.74 kJ/g of substrate (27, 28) as metabolic energy equivalents for carbohydrate, fat, and protein, respectively, Pox (in g/d) was estimated from REE (in kJ/d) as
By using established formulas (5, 9, (24) (25) (26) (27) (28) , Gox and Fox (in g/d) were estimated from VCO 2 and VO 2 (mL/min) as
The relative energy contribution of carbohydrate and fat oxidation (ie, Gox% and Fox% in % REE) to total energy expenditure is given by
Foxð%Þ ¼ ðFox 3 37:24=REEÞ 3 100 ð8Þ
In vitro studies
Estimates for the expected VCO 2 and VO 2 in the simulation experiments in which defined infusion rates of gaseous CO 2 and N 2 (V infusedCO 2 and V infusedN 2 in standard liters per minute, normalized to a standard temperature of 08C and pressure of 1013 hPa) were applied to mimic different rates of gas exchange rates considered the use of the Haldane transformation by the metabolic carts and were obtained as follows: O 2 uptake (VO 2 ) and CO 2 exhalation (VCO 2 ) at a given rate of inspiration (V i ) and expiration (V e ) is calculated by
F i and F e represent the appropriate fractional amount of O 2 and CO 2 in the inspiratory and expiratory gas mixture, respectively.
V e is known and adjusted by the metabolic cart (= V adj ), whereas V i is unknown. The latter is derived by using the Haldane transformation. It is assumed that F iN 2 
This is equivalent to
Thus, O 2 uptake and CO 2 output rates are calculated by the metabolic carts as
and
In the simulation experiments, natural abundance in ambient air was assumed and fractional amounts of O 2 and CO 2 in inspired and expired air are given by the equations 
On the basis of on these fractions, estimates of the rates of O 2 consumption and CO 2 output (V calc ) due to infusion of gaseous N 2 and CO 2 were calculated as
Of note, under the present test conditions, the correction for influence of infusion of CO 2 on V calcO 2 and of N 2 on V calcCO 2 is ,,1% and can thus actually be neglected.
Results are the within-series means of the 10 and 30 data points as obtained by the 10-min recordings with the Deltatrac and the Vmax Encore, respectively, and RQ data were derived from the appropriate breath gas exchange variables as in the in vivo studies.
Statistical analyses
Results are presented as means 6 SD (median and range in parentheses). Linear regression (least-squares method) was applied for correlation analysis. Differences between paired or unpaired data sets were assessed by using 2-tailed Student's t test as appropriate. Significant differences required P , 0.05. Inter-and intraindividual CVs (CV i ) were calculated from the total CV (CV t ) and analytic CV (CV a ) as Table 1 ). Bland-Altman plots of VCO 2 (A, C) and VO 2 (B, D) data are shown. Mean differences between carts and ranges for 61.96 SD and 95% CIs are indicated. Abs., absolute; CI lower , lower CI; CI upper , upper CI; DT, Deltratrac MBM-100; Rel., relative; VCO 2 , carbon dioxide output rate; Vmax, Vmax Encore 29n; VO 2 , oxygen consumption rate.
Method comparison was visualized by using Bland-Altman plots. The 95% limits of agreement (CL) were calculated as
The limits of the 95% CI were calculated as
and are shown as recommended (29) (30) (31) (32) .
RESULTS
Comparative in vivo assessment of the metabolic carts
The metabolic carts were compared by performing parallel IC measurements in 40 fasted subjects under strictly controlled conditions. A summary of results is presented in Table 2 . Significant differences between carts were found with all variables (P , or ,, 0.02). Correlation between carts was only moderate for the primary variables VCO 2 and VO 2 and REE (R 2 . 0.86), poor for RQ (R 2 , 0.35), and unacceptable for the estimates for macronutrient oxidation (Gox and Fox, R 2 , 0.15).
Variations were essentially due to a distinct variability in VCO 2 and VO 2 measurement (see Figure 1) . In relation to the mean value of both methods, the relative differences of both devices (ie, Vmax Encore minus Deltatrac) in VCO 2 and VO 2 were 27 6 6% (range: 222 to +8%) and 22 6 4% (214 to +5%), respectively.
These differences propagated differentially into derived metabolic estimates. With REE, the mean relative difference was small and amounted to 23 6 4% (213 to +6%). With RQ, the mean difference was 0.044 6 0.042 (20.15 to +0.04) units (Figure 2) . Macronutrient oxidation estimates were strongly affected. The mean relative differences were 247 6 59% (2182 to +122%) with Gox and 23 6 57% (2200 to +200%) with Fox, and correlation between methods was practically abolished (see Figure 3 ).
In vitro evaluation of cart performance characteristics
Toward an explanation of the differences between monitors, in vitro simulation experiments were performed in parallel with both carts by using calibrated gas-flow regulators and a pure mixture of 21% CO 2 in N 2 to imitate VCO 2 and VO 2 at a fixed RQ = 1.00. Figure 1 ). Bland-Altman plots of data on REE (A, C) and RQ (B, D) are shown. Mean differences between the 2 methods and ranges for 61.96 SD and 95% CIs are indicated. Abs., absolute; CI lower , lower CI; CI upper , upper CI; DT, Deltratrac MBM-100; REE, resting energy expenditure; Rel., relative; RQ, respiratory quotient; Vmax, Vmax Encore 29n.
Accuracy of VCO 2 and VO 2 readouts
In simulation experiments (n = 9) comprising 20 different flow rates in series (range: .0.1 to ,0.5 L/min), linear-regression estimates of slope and intercept between cart readouts and massflow regulator-adjusted flow were 1.0 and within 60.018 L/min, respectively, and overall R 2 was .0.995 with either cart (see Supplementary Figure 1 under "Supplemental data" in the online issue). A closer inspection of data showed distinct differences.
Between devices, VCO 2 and VO 2 were significantly different (P , or ,, 0.05) in a nonlinear fashion over the whole measuring range and at a flow .0.27 L/min, respectively (see Supplementary Figure 2 under "Supplemental data" in the online issue).
The deviation of readouts from adjusted values is shown in Figure 4 . With the Deltatrac, differences were significant (P , or ,, 0.05) over the whole range and with the Vmax Encore at flows ,0.22 L/min. Deviations in Deltratrac readouts of VCO 2 and VO 2 were approximately linear and inverse linear correlated to the mass-flow regulator-adjusted flow, respectively. A complex nonlinear deviation pattern was found with the Vmax Encore. Of note, interassay variability in readouts was high, leading to a considerable broadening of confidence limits with both carts.
Variability and long-term stability
In simulation experiments, the CVs of VCO 2 and VO 2 readouts were ,1% within series and ,3% between series with both monitors. With the Vmax Encore, within-and between-series CVs tended to be higher than with the Deltatrac ( Table 3) . Long-term stability (10-h period) was excellent with both carts, although some significant but very low drifts were observed at higher flow rates ( Table 4) .
Fractional mean estimates for the impact of analytic variability on metabolic cart measurements of VCO 2 and VO 2 in humans were as follows-within series: ,0.02; between series: ,0.04 and ,0.20 for interindividual and intraindividual assays, respectively ( Table 5) .
Exploitation of RQ readouts
The RQ in simulation experiments was 1.0045 units throughout. The Deltatrac readouts yielded significantly elevated RQ values over the whole flow range, with a mean increment of +0.090 6 0.026 units (range: 0.025-0.176 units) (n = 180). With the Vmax Encore, the mean RQ was not significantly different from the assigned value and amounted to 0.002 6 0.033 units (range: 20.048 to 20.102 units; see Supplementary Figure 3 under "Supplemental data" in the online issue).
Together, these variabilities point at the physiologically significant impact of cart readout errors on derived secondary metabolic variables.
Impact of cart series
Due to the inherent variability of metabolic monitors, cart differences might also be suspected in instruments of the same type. In fact, when series of simulation assays were performed using 2 Vmax Encore devices of identical construction (ie, Vmax Encore 29n) in parallel, considerable variability in simultaneously obtained VCO 2 and VO 2 readouts was found with but minor effects on the overall mean values ( Supplementary Figure 4 under "Supplemental data" in the online issue).
Accomplishment of accurate IC measurements in humans by individual calibration control evaluation
To reduce interferences of metabolic cart deviations and variability in human studies, the postcalorimetric individual calibration control evaluation (ICcE) procedure was introduced. The procedure evaluates cart performance for each individual IC measurement by an appropriate in vitro simulation measurement.
Value of case-related in vitro validation
The relevance of ICcE was evaluated in vivo by performing comparative IC measurements with Deltratrac and Vmax Encore devices in postabsorptive subjects (n = 22). A summary of data is presented in Table 6 . Distribution of and variation in VCO 2 and VO 2 readouts and in derived metabolic variables were comparable to the findings in the first in vivo study, and cart-dependent differences were confirmed.
By means of ICcE, distinct errors of the individual VCO 2 and VO 2 readouts were detected, which were comparable to the findings in the in vitro simulation studies (see Supplementary Figure 5 under "Supplemental data" in the online issue). Accordingly, considerable error was found in the derived estimates for REE, RQ, Gox, and Fox (see Supplementary Figure 6 under "Supplemental data" in the online issue).
Adjustment of the individual cart readout for the deviations detected by the ICcE procedure resulted in a considerably better agreement of results. Although some minor differences remained, in particular with the VCO 2 values, the correlation between methods improved significantly. In this data set, the coefficients of determination R 2 for the primary variables, VCO 2 and VO 2 , were 0.936 and 0.953, respectively, and for the estimates of the derived variables REE, RQ, Gox, and Fox were 0.922, 0.929, 0.939, and 0.927, respectively.
DISCUSSION
Among metabolic monitors, the Deltatrac was supposed to provide the greatest accuracy and least intercart variability of all such devices worldwide (ie, a "gold standard" for canopy-based IC), but it is no longer produced (14, 21, 25) . In the present study in healthy volunteers, we compared the Deltatrac with the Vmax Encore metabolic monitor. The data were similar to results reported by Cooper et al (25) . The primary data, ie, breath gas exchange rates, as well as the derived secondary metabolic results differed significantly between devices, although carefully designed preparatory measures were imposed on the subjects under study and strictly controlled experimental conditions were applied for the measurements. Specifically, mean VCO 2 was found to be substantially higher with the Deltatrac, with more subtle differences in VO 2 measurements. Accordingly, REE estimates, which depend primarily on VO 2 , differed less markedly, but marked differences were observed with the estimates for RQ, Gox, and Fox. On the whole, differences in cart readouts led to a physiologically relevant variability between methods with a generally poor correlation of data and an essentially unacceptable correlation of the estimates of RQ, Gox, and Fox.
However, because no uniform procedure is available to ensure accuracy and precision of metabolic carts, virtually no final preference can be assigned to either cart. Thus, the causes for the differences remain obscure. We therefore conducted an analysis of performance with either cart by in vitro simulation experiments with the use of pure gases and calibrated gas-flow regulators. The outcome, however, was somewhat disillusioning. The Deltatrac, the presumed reference cart, exhibited physiologically significant variation in measurements within series with respect to a ratedependent deficiency of accuracy as well as between series with respect to a variable imprecision in repeatability. Similar problems with accuracy and repeatability were encountered with the Vmax Encore. Interestingly, however, the performance characteristics showed distinct differences, eg, with a nearly linear rate dependence of accuracy with the Deltatrac compared with a nonlinear dependence with the Vmax Encore. Of note, the effect of device-inherent variability on differences in the measurements was also shown when parallel examinations were performed with 2 identical Vmax Encore carts.
Clearly, an inevitable within-and between-series variability in metabolic carts exists. Thus, deviation of the cart readout from the true value cannot be predicted reliably. Any given individual measurement is therefore uncertain to an unknown extent. In principle, confidence limits for a cart readout can be estimated from the present experimental data, but these variables are inappropriate for evaluation of an individual measurement or repeat measurements in one subject at different occasions. Variability within carts of the same series may finally level out in populationbased studies with large numbers of participants but will remain in studies in which different carts devices are applied. In the latter case, data may additionally be confounded by device-specific differences in accuracy.
The foregoing considerations point toward the need for rigorous control of intra-and interdevice variability as a necessary 1 Data are percentages as evaluated in analyses with a fixed VCO 2 :VO 2 ratio (adjusted by infusion of a calibrated gas mixture of 21% CO 2 in N 2 ) and variable gas-flow rates (between 0.1 and 0.5 L/min adjusted by means of calibrated mass-flow regulators; see Supplemental Figure 1 under "Supplemental data" in the online issue). Ten-minute recordings were performed under steady state conditions by using the maximal rate of data readout (ie, Vmax Encore, 3 readouts/min; Deltatrac, 1 readout/min). VCO 2 , carbon dioxide output rate; VO 2 , oxygen consumption rate.
2 SensorMedix. 3 Datex. 4 Values are based on successive serial measurements of VCO 2 and VO 2 at 20 different rates, respectively (see Supplemental Figure 1 under "Supplemental data" in the online issue), with a total of 9 repeats performed on different working days. Of note, CVs were essentially independent from the flow rate. 5 Mean 6 SD (all such values). requirement for a reasonable comparability of data from canopybased IC studies in humans. The possible effect of device-specific variability on the primary readout of metabolic monitors and the impact on derived metabolic variables have not been appropriately reviewed in the literature (8, 9, (13) (14) (15) (16) (17) (20) (21) (22) (23) (24) (25) .
To overcome these problems, we have now developed a new postcalorimetric procedure, ie, the ICcE, for quantitative evaluation of each individual measurement. To avoid any change in performance or setup of the instrument, this evaluation procedure has to be performed in series directly after an IC assessment. The 1 As evaluated in 20-min standard indirect calorimetry recordings in postabsorptive healthy subjects (cohort 1; see Table 1 and footnote 1 of Table 2 ). For comparative purposes, metabolic data were normalized to unit weight of lean body mass. CL, confidence limit; VCO 2 , carbon dioxide output rate; VO 2 , oxygen consumption rate.
2 Means 6 SDs of series with 40 different participants (see footnote 1 of Table 2 ). 3 Estimates were based on the analytic imprecision data compiled in Table 4 ; the maximum is indicated as the 95% CL. 4 SensorMedix. 5 Datex. 6 Variability of measurements in 40 different subjects (see above). 7 Means 6 SDs from 6 healthy subjects undergoing a series of 4 different intraindividual measurements within a mean period of 3 mo (see Subjects and Methods). 1 Twenty-two postabsorptive subjects without stated acute or chronic illness received immediate subsequent indirect calorimetry measurements with both metabolic carts in random order. Results are presented as means 6 SDs; median and range in parentheses). I-III Significant differences (Student's t test)-I: vs appropriate cart readout, P , or ,, 2 3 10 26 ; II: between carts, P , or ,, 3 3 10 29 ; III: between carts, P , 0.005. Fox, fat oxidation (protein oxidation was assumed to account for 15% of total REE; see Subjects and Methods for details); Gox, glucose/carbohydrate oxidation; NA, not applicable; NS, no difference between carts; REE, resting energy expenditure; RQ, respiratory quotient; VCO 2 , carbon dioxide output rate; VO 2 , oxygen consumption rate. 2 SensorMedix. 3 Datex. 4 Cart readouts were calibrated for each individual in a subsequent simulation experiment (ie, mass-flow regulator infusion of pure gaseous CO 2 and N 2 as detailed in Subjects and Methods). 5 Means 6 SDs of deviation of readouts as related to calibrated estimates (with the minimal/maximal deviation in parentheses).
determination of the appropriate deviations in the cart readout from the true in vivo values is achieved by mimicking the readout of the in vivo measurement. This is done in vitro by simulating exactly the in vivo rate readout by means of mass-flow regulatorcontrolled infusion of pure gaseous CO 2 and N 2 via appropriate tubes into the hose of the flow-through system of the metabolic cart. In detail, the flow of gaseous CO 2 is upregulated via the regulator until the cart readout exactly matches the mean VCO 2 that was observed in the previous in vivo measurement. The best estimate for the true value for VCO 2 in the patient is now shown directly on the CO 2 -flow regulator. Similarly, the N 2 flow (V N 2 ) is upregulated to yield a cart readout that matches the mean VO 2 in vivo. The best estimate for O 2 consumption rate in vivo is calculated from V N 2 as V O 2 = V N 2 3 0.2646. The factor accounts for 1) the fact that N 2 infused in the system replaced not only oxygen but whole room air and 2) the numeric contribution of the Haldane transformation on the metabolic cart readout. According to our experience, the mean in vivo values can be reproduced in vitro on the metabolic cart with an agreement better than 62 mL/min in w15 min. Of note, for reliable and accurate performance of the ICcE, it is mandatory that the gas-flow regulators are carefully maintained and (re)calibrated according to the manufacturers' recommendations and that the standard temperature pressure dry conditions applied for regulator calibration are identical to those that are used in the metabolic cart under evaluation.
The applicability and usefulness of the ICcE procedure were verified in another Deltatrac compared with Vmax Encore IC study in vivo. In this human study, the agreement of the metabolic variable estimates for REE, RQ, and the macronutrient oxidation rates (Gox and Fox) increased significantly, and only minor differences between the 2 carts remained.
In conclusion, the ICcE procedure established in this study appears to be suitable to control for variability in devices based on flow-through respiratory measurements in canopy mode, independent of device, time, and place.
